This was a 24-month, multicentre, non-interventional study designed to study physicians adherence to SPC in patients with osteoporosis indicated to zoledronic acid (Aclasta) treatment. Primary assessment was to consider the percentage of patients who underwent standard procedures, e.g. creatinine and calcium measurement, adequate hydration and antiphlogistics administration.
The results show a satisfactory compliance with instructions specified in SPC.